Shares +900% to C$0.05: CHM.CN Waverunner Capital (CNQ) 26 Jan 2026 catalyst

The CHM.CN stock surged 900% to C$0.05 on Jan 26 2026 during market hours, marking a sharp move from a previous close of C$0.005. That price change, combined with an average daily volume of 28,908 shares, flags the name as a high-volume mover on the CNQ exchange in Canada. Traders should note the lack of an official intraday print for today’s volume, but the price spike and the stock’s 50-day average of C$0.0424 suggest renewed interest. This report covers the price action, valuation, Meyka AI grade, realistic price targets, and short-term trading cues for Waverunner Capital Inc. (CHM.CN)

CHM.CN stock price action and volume

CHM.CN stock rose from a previous close of C$0.005 to C$0.05, a +900.00% intraday change that is driving screens. The reported day low and high are both C$0.05, and a year high sits at C$0.10 while the year low is C$0.05. Volume data for the session is not available at the time of writing; track the tape against the avgVolume of 28,908 shares to confirm a genuine liquidity spike.

This price move likely reflects a combination of corporate rebranding, news flow from legacy filings, or speculative trading in microcap healthcare names. On CNQ, sudden percentage moves often attract short-term momentum traders; always verify trade prints and spreads before entering a position.

CHM.CN stock fundamentals and valuation

Waverunner Capital Inc. operates as a venture investor in early-stage and renewable energy ventures and changed its name from Chemistree Technology in June 2024. The company shows EPS of -0.01 and a trailing PE of -5.00, reflecting negative earnings and a small market capitalization of C$37,211,650.00. Book value per share is negative at -0.11, cash per share is 0.01, and the company has 744,233,000 shares outstanding.

Those metrics place CHM.CN stock in the high-risk microcap bucket: low liquidity, negative equity per share, and weak cash coverage (current ratio 0.16). Investors should treat valuation measures as limited guides while prioritizing balance sheet events and capital raises as key drivers.

CHM.CN stock technicals and Meyka AI grade

Technically, CHM.CN price sits above its 50-day average of C$0.0424 and roughly in line with its 200-day average of C$0.0481, which points to near-term positive momentum but still limited trading history. The stock’s one-year move shows a +400.00% change, but longer-term returns remain negative versus peak levels.

Meyka AI rates CHM.CN with a score out of 100: 60.93 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. These grades are informational only and not guaranteed; they do not constitute financial advice.

CHM.CN stock catalysts, risks and sector context

Primary catalysts for CHM.CN stock include company-level financing, portfolio realization events in its venture holdings, and any new investment or asset sale announcements. Waverunner’s exposure to renewable energy and biotech ventures can create episodic re-rating events in the Healthcare sector, where peers show mixed performance: the Canada Healthcare sector has an average PE of 14.48 and average volume near 214,043 shares.

Key risks include very low liquidity, negative book value, recurring operating losses, and the potential for dilution via financings. With cash per share at 0.01 and weak current coverage, follow any filings for capital raises closely.

CHM.CN stock forecast and price targets

Meyka AI’s forecast model projects a 12-month base case target of C$0.08, a conservative target of C$0.04, and a bullish scenario of C$0.12 based on potential asset realizations and improved trading liquidity. Compared with the current price of C$0.05, the base case implies an implied upside of 60.00%, the conservative target implies -20.00%, and the bullish target implies 140.00%. Forecasts are model-based projections and not guarantees.

Analyst-style price targets for microcaps vary widely; use these figures to size risk and set stop-loss levels rather than as trade endorsements.

CHM.CN stock trading plan and what to watch next

Short-term traders should watch for confirmed volume above the avgVolume 28,908 and narrowing bid-ask spreads before committing capital. Monitor SEDAR filings for financings, insider activity, and material change filings from Waverunner Capital. If volume confirms the move, intraday momentum plays could be possible but require tight risk control.

Longer-term investors should demand clarity on asset value in the company’s portfolio, cash runway, and any announced monetization events. Given negative equity and cash constraints, consider a position only with explicit capital structure and dilution disclosures in hand.

Final Thoughts

CHM.CN stock registered a dramatic intraday move to C$0.05, a +900.00% change from the prior close, which flags it as a high-volume mover in the CNQ market landscape. Fundamentals remain thin: EPS -0.01, PE -5.00, negative book value, and modest cash per share at 0.01, so any upside should be balanced against dilution and liquidity risk. Meyka AI’s forecast model projects a C$0.08 base case target (implied +60.00% vs C$0.05) and provides a range from C$0.04 to C$0.12 under conservative and bullish scenarios. These model projections are not guarantees; they are tools for scenario planning. For traders, confirm volume prints and narrow spreads; for investors, await clear corporate updates or asset realizations. Use tight position sizing and stop-loss discipline given the microcap profile and sector volatility in Healthcare.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.